Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļBAX
āļāļ·āđāļāļāļĢāļīāļĐāļąāļBaxter International Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļJun 20, 2097
āļāļĩāļāļĩāđāļHider (Andrew P)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ38000
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļJun 20
āļāļĩāđāļāļĒāļđāđOne Baxter Parkway
āđāļĄāļ·āļāļDEERFIELD
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX NASDAQ Basic NYSE
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ60015
āđāļāļĢāļĻāļąāļāļāđ12249482000
āđāļ§āđāļāđāļāļāđhttps://www.baxter.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļBAX
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļJun 20, 2097
āļāļĩāļāļĩāđāļHider (Andrew P)
Mr. Andrew P. Hider
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
Mr. Reazur Rasul
Executive Vice President, Group President - Healthcare Systems and Technologies
Executive Vice President, Group President - Healthcare Systems and Technologies
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Ms. Patricia B. (Patty) Morrison
Ms. Patricia B. (Patty) Morrison
Independent Director
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Director
Mr. Jeffrey A. (Jay) Craig
Mr. Jeffrey A. (Jay) Craig
Independent Director
Ms. Nancy M. Schlichting
Lead Independent Director
Lead Independent Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Andrew P. Hider
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
Mr. Reazur Rasul
Executive Vice President, Group President - Healthcare Systems and Technologies
Executive Vice President, Group President - Healthcare Systems and Technologies
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
iShares Large Cap Value Active ETF
First Trust Indxx Medical Devices ETF
Invesco Raymond James SB-1 Equity ETF
State Street SPDR S&P Health Care Equipment ETF
Invesco S&P 500 Equal Weight Health Care ETF
Franklin US Dividend Booster Index ETF
iShares U.S. Medical Devices ETF
Invesco Zacks Multi-Asset Income ETF
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
iShares Large Cap Value Active ETF
āļŠāļąāļāļŠāđāļ§āļ2.23%
First Trust Indxx Medical Devices ETF
āļŠāļąāļāļŠāđāļ§āļ1.69%
Invesco Raymond James SB-1 Equity ETF
āļŠāļąāļāļŠāđāļ§āļ1.5%
State Street SPDR S&P Health Care Equipment ETF
āļŠāļąāļāļŠāđāļ§āļ1.37%
Invesco S&P 500 Equal Weight Health Care ETF
āļŠāļąāļāļŠāđāļ§āļ1.26%
Franklin US Dividend Booster Index ETF
āļŠāļąāļāļŠāđāļ§āļ1.26%
iShares U.S. Medical Devices ETF
āļŠāļąāļāļŠāđāļ§āļ1.13%
Invesco Zacks Multi-Asset Income ETF
āļŠāļąāļāļŠāđāļ§āļ0.8%
Humankind US Stock ETF
āļŠāļąāļāļŠāđāļ§āļ0.76%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
āļŠāļąāļāļŠāđāļ§āļ0.57%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
2.28B
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē
BAX.NB Final Cash Dividend of gross USD 0.01 paid on Apr 01, 2026 going ex on Feb 27, 2026
BAX.NB Interim Cash Dividend of gross USD 0.01 paid on Apr 01, 2026 going ex on Feb 27, 2026 with reinvestment option
BAX.NB Final Cash Dividend of gross USD 0.01 paid on Jan 02, 2026 going ex on Nov 28, 2025 with reinvestment option
BAX.NB Interim Cash Dividend of gross USD 0.17 paid on Oct 01, 2025 going ex on Aug 29, 2025 with reinvestment option
BAX.NB Interim Cash Dividend of gross USD 0.17 paid on Jul 01, 2025 going ex on May 30, 2025 with reinvestment option
BAX.NB Interim Cash Dividend of gross USD 0.17 paid on Apr 01, 2025 going ex on Feb 28, 2025 with reinvestment option
BAX.NB Final Cash Dividend of gross USD 0.17 paid on Jan 02, 2025 going ex on Nov 29, 2024 with reinvestment option
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Oct 01, 2024 going ex on Aug 30, 2024 with reinvestment option
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Jul 01, 2024 going ex on May 31, 2024 with reinvestment option
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Apr 01, 2024 going ex on Feb 29, 2024 with reinvestment option
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ